Posted at 02:41 PM, 28 April 2016 by grmklnadmin1 / Category: healthcare, MERS
In September 2012, media reports from Dubai suggested a Middle East patient had been repatriated to London as there was a fear that he had contracted a new strain of Coronavirus – a virus from the same genus as SARS. Subsequent tests confirmed the man had indeed contracted a new strain – a strain now referred to as Middle East Respiratory Syndrome, or MERS.
As MERS has proven fatal in an alarming percentage of patients, Middle East authorities sent out a global call seeking a suitable product that had been proven in an independent, GLP accredited Laboratory to be effective against the MERS virus.
Prompted by this call, Zoono Limited sent samples of Zoono Z-71 Surface Sanitiser to MikroLab GmbH (now the Institute for Hygiene and Microbiology, Bremen), for full evaluation against the MERS virus in accordance with the European Standard EN14476:2013.
In summary: Zoono Z-71 Surface Sanitiser achieved a Log 4.25 (99.99%) kill rate against MERS.
New Zealand based Zoono CEO Paul Hyslop said: “MikroLab is considered one of the world’s specialist Laboratories for viruses, so we’re delighted with this breakthrough Test Result.
He added: “We test our brands globally, but this result is particularly satisfying – our research team is always working to improve Zoono technology, so this is just reward for their efforts.”
Hyslop concluded: “Even MikroLab noted the results were ‘excellent’ when they broke the news to us. Given the 99.99% kill rate, we could only agree”.
ZNO Price at posting:
24.5¢ Sentiment: Buy Disclosure: Held
